Article ID Journal Published Year Pages File Type
10008843 Annals of Allergy, Asthma & Immunology 2005 6 Pages PDF
Abstract
The study confirmed the efficacy of levocetirizine in relieving symptoms of perennial allergic rhinitis in children between 6 and 12 years of age. A HRQL benefit greater than placebo was shown. The treatment was well tolerated.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Preview
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial
Authors
, ,